| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.282 | 7.567 | 10.732 | 7.844 | 20.157 |
| Total Income - EUR | - | - | - | - | - | 11.282 | 7.567 | 11.010 | 8.135 | 23.732 |
| Total Expenses - EUR | - | - | - | - | - | 2.602 | 135 | 10.366 | 6.374 | 23.141 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.679 | 7.432 | 644 | 1.761 | 591 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.416 | 7.250 | 385 | 1.550 | 507 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Davicom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.021 | 5.605 | 5.588 | 9.080 |
| Current Assets | - | - | - | - | - | 8.769 | 13.576 | 7.734 | 13.081 | 8.853 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 201 |
| Receivables | - | - | - | - | - | 6.746 | 0 | 29 | 4.043 | 23 |
| Cash | - | - | - | - | - | 2.024 | 13.576 | 7.705 | 9.038 | 8.630 |
| Shareholders Funds | - | - | - | - | - | 8.480 | 15.542 | 15.976 | 17.477 | 17.886 |
| Social Capital | - | - | - | - | - | 64 | 63 | 63 | 63 | 62 |
| Debts | - | - | - | - | - | 289 | 55 | 0 | 1.192 | 47 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1013 - 1013" | |||||||||
| CAEN Financial Year |
162
|
|||||||||
Comments - Bio Davicom Srl